AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vitrafy Life Sciences Ltd

3.670

-0.120-3.17%

Volume:26.59K

Turnover:96.86K

Market Cap:279.50M

PE:-14.58

High:3.800

Open:3.800

Low:3.590

Close:3.790

52wk High:4.660

52wk Low:1.160

Shares:76.16M

Float Shares:33.74M

Volume Ratio:0.45

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.252

EPS(LYR):-0.252

ROE:-46.29%

ROA:-27.94%

PB:6.80

PE(LYR):-14.58

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Australia's Vitrafy Life Sciences Gains on Entering US Market

Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement

THOMSON REUTERS

Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million

Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/VFY.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VFY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","market":"AU","secType":"STK","nameCN":"Vitrafy Life Sciences Ltd","latestPrice":3.67,"timestamp":1789020720000,"preClose":3.79,"halted":0,"volume":26594,"delay":0,"changeRate":-0.03166226912928763,"nameEN":"Vitrafy Life Sciences Ltd","floatShares":33735952,"shares":76157278,"eps":-0.2518,"marketStatus":"Not Yet Opened","change":-0.12,"latestTime":"09-10 16:12:00 AEST","open":3.8,"high":3.8,"low":3.59,"amount":96862,"amplitude":0.055409,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2518,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.79,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":0.44584150524734734,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"VFY.AU","preClose":3.79,"auctionPrice":3.67,"auctionVolume":17,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020585312}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","floatShares":33735952,"roa":"-27.94%","roe":"-46.29%","lyrEps":-0.2518,"volumeRatio":0.44584150524734734,"shares":76157278,"dividePrice":0,"high":3.8,"amplitude":0.055409,"preClose":3.79,"low":3.59,"week52Low":1.16,"pbRate":"6.80","psRate":"1337.33","week52High":4.66,"institutionHeld":0,"latestPrice":3.67,"eps":-0.2518,"divideRate":0,"volume":26594,"delay":0,"ttmEps":-0.2518,"open":3.8,"prevYearClose":1.28,"prevWeekClose":3.87,"prevMonthClose":3.85,"prevQuarterClose":3.01,"fiveDayClose":3.93,"twentyDayClose":4.17,"sixtyDayClose":2.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VFY.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"VFY.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"Pre-MKt","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-04-28","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777334400000,"name":null,"time":"","dateTimestamp":1777298400000,"actualEps":null},{"date":"2026-02-03","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770073200000,"name":null,"time":"","dateTimestamp":1770037200000,"actualEps":null},{"date":"2025-10-21","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761001200000,"name":null,"time":"","dateTimestamp":1760965200000,"actualEps":null},{"date":"2025-08-05","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754352000000,"name":null,"time":"","dateTimestamp":1754316000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VFY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VFY.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664893380","title":"Australia's Vitrafy Life Sciences Gains on Entering US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893380","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893380?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:10","pubTimestamp":1788318627,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Vitrafy Life Sciences gains on entering US market** Shares of Australia's Vitrafy Life SciencesVFY.AXrise as much as 6.7% to A$4.110, hitting their highest level since August 24** Cel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U09J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886441","title":"Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886441?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:17","pubTimestamp":1788304672,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656852125","title":"Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656852125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656852125?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:26","pubTimestamp":1785806787,"startTime":"0","endTime":"0","summary":"BRIEF-Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 MillionAug 4 (Reuters)-Vitrafy Life Sciences LtdVFY.AX:FY OPERATING LOSS A$14.6 MILLIONFurther company coverage:VFY.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656557300","title":"Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2656557300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656557300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:24","pubTimestamp":1785795887,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VFY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}